These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 10867384

  • 21. [Antileukotrienes in asthma - critical view].
    Droszcz W.
    Pneumonol Alergol Pol; 2010; 78(1):60-7. PubMed ID: 20162520
    [Abstract] [Full Text] [Related]

  • 22. [Effectiveness and safety of montelukast versus budesonide at various doses on bronchial reactivity in subjects with mild persistent asthma].
    Riccioni G, D'Orazio N, Di Ilio C, Della Vecchia R, De Lorenzo A.
    Clin Ter; 2002; 153(5):317-21. PubMed ID: 12510415
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 24. Discrepant clinical responses and blood chemokine profiles between two non-steroidal anti-inflammatory medications for children with mild persistent asthma.
    Hung CH, Li CY, Lai YS, Hsu PC, Hua YM, Yang KD.
    Pediatr Allergy Immunol; 2005 Jun; 16(4):306-9. PubMed ID: 15943593
    [Abstract] [Full Text] [Related]

  • 25. Montelukast for persistent asthma.
    Med Lett Drugs Ther; 1998 Jul 17; 40(1031):71-3. PubMed ID: 9698701
    [No Abstract] [Full Text] [Related]

  • 26. [Leukotriene antagonists against bronchial asthma. Not a replacement for steroids].
    MMW Fortschr Med; 1999 Sep 23; 141(38):56. PubMed ID: 10904622
    [No Abstract] [Full Text] [Related]

  • 27. Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma.
    van Adelsberg J, Moy J, Wei LX, Tozzi CA, Knorr B, Reiss TF.
    Curr Med Res Opin; 2005 Jun 23; 21(6):971-9. PubMed ID: 15969897
    [Abstract] [Full Text] [Related]

  • 28. Real-life effectiveness of Singulair (montelukast) in 506 children with mild to moderate asthma.
    Amirav I.
    Isr Med Assoc J; 2008 Apr 23; 10(4):287-91. PubMed ID: 18548983
    [Abstract] [Full Text] [Related]

  • 29. Leukotrienes in respiratory disease.
    McMillan RM.
    Paediatr Respir Rev; 2001 Sep 23; 2(3):238-44. PubMed ID: 12052325
    [Abstract] [Full Text] [Related]

  • 30. [Effects of Tilade in asthma].
    Godard P.
    Rev Mal Respir; 1992 Sep 23; 9 Suppl 1():R103-5. PubMed ID: 1317050
    [Abstract] [Full Text] [Related]

  • 31. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
    Szefler SJ, Baker JW, Uryniak T, Goldman M, Silkoff PE.
    J Allergy Clin Immunol; 2007 Nov 23; 120(5):1043-50. PubMed ID: 17983871
    [Abstract] [Full Text] [Related]

  • 32. Antileukotrienes in asthma: present situation.
    García-Marcos L, Schuster A.
    Expert Opin Pharmacother; 2001 Mar 23; 2(3):441-66. PubMed ID: 11336598
    [Abstract] [Full Text] [Related]

  • 33. Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA).
    Lee SY, Kim HB, Kim JH, Kim BS, Kang MJ, Jang SO, Seo HJ, Hong SJ.
    Clin Exp Allergy; 2007 Oct 23; 37(10):1487-93. PubMed ID: 17883728
    [Abstract] [Full Text] [Related]

  • 34. Inhaled corticosteroids or antileukotrienes for asthma?
    Hampson NB.
    Ann Intern Med; 1999 Dec 07; 131(11):865. PubMed ID: 10610635
    [No Abstract] [Full Text] [Related]

  • 35. [Anti-leukotrienes in allergic diseases in children].
    Jung A.
    Pol Merkur Lekarski; 2003 Jun 07; 14(84):631-3. PubMed ID: 14524289
    [Abstract] [Full Text] [Related]

  • 36. Leukotriene receptor antagonists pranlukast and montelukast for treating asthma.
    Matsuse H, Kohno S.
    Expert Opin Pharmacother; 2014 Feb 07; 15(3):353-63. PubMed ID: 24350802
    [Abstract] [Full Text] [Related]

  • 37. Montelukast, current indications and prospective future applications.
    Kittana N, Hattab S, Ziyadeh-Isleem A, Jaradat N, Zaid AN.
    Expert Rev Respir Med; 2016 Sep 07; 10(9):943-56. PubMed ID: 27485393
    [Abstract] [Full Text] [Related]

  • 38. [The therapeutic potentials of antileukotriene preparations in bronchial asthma patients].
    Fedoseev GB, Emel'ianov AV, Krasnoshchekova OI.
    Ter Arkh; 1998 Sep 07; 70(8):81-4. PubMed ID: 9770758
    [No Abstract] [Full Text] [Related]

  • 39. Asthma treatment: antileukotriene drugs.
    O'Byrne PM.
    Can Respir J; 1998 Sep 07; 5 Suppl A():64A-70A. PubMed ID: 9753521
    [Abstract] [Full Text] [Related]

  • 40. Asthma controller therapy: role of antileukotrienes, a new therapeutic class.
    Allegra L, Canonica GW, Donner CF, Fogliani V, Melillo G, Mistretta A, Paggiaro PL, Rossi GA, Sanguinetti CM, Vignola M.
    Monaldi Arch Chest Dis; 1999 Apr 07; 54(2):136-45. PubMed ID: 10394828
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.